Alaunos Therapeutics, Inc.

Historical 13F Holders

Symbol
TCRT
CUSIP
98973P309
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 98973P309 since 12/18/2024, newest first.

Filer % of Class Filed
Price Adrian 13D/A Amendment 4
8.6% 3/5/2026
Event 2/24/2026
Price Adrian 13D/A Amendment 3
8.6% 2/24/2026
Event 2/24/2026
Price Adrian 13D/A Amendment 2
8.6% 12/5/2025
Event 10/30/2025
Price Adrian 13D/A Amendment 1
8.6% 10/31/2025
Event 10/30/2025
Price Adrian 13D
8.6% 10/30/2025
Event 10/30/2025
Strategic EP, LLC 13G/A Amendment 1 0% 10/16/2025
Event 10/14/2025
PMGC Capital LLC 13D/A Amendment 1
0% 9/5/2025
Event 8/22/2025
Strategic EP, LLC 13G 6.8% 9/4/2025
Event 8/21/2025
Postma Robert W 13D
9.0% 7/1/2025
Event 6/24/2025
PMGC Capital LLC 13D
5.1% 5/14/2025
Event 5/12/2025
MSD Partners, L.P. 13G/A Amendment 5
0% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 29 90.4 k $204 k
2026 Q1 29 126 k $361 k
2025 Q4 27 109 k $350 k
2025 Q3 26 65.4 k $158 k
2025 Q2 29 71.1 k $345 k
2025 Q1 30 70.7 k $103 k
2024 Q4 31 72.1 k $137 k
2024 Q3 30 192 k $623 k
2024 Q2 3 37.0 $25.00